TLDR
- JPMorgan upgraded Corteva to Buy from Hold, with a new price target of $19
- The target cut from $83 looks dramatic but reflects the Oct. 1 spinoff, not a real downgrade in value
- Corteva spun out its seed technology business into a new company called Vylor
- JPMorgan sees fair value near $21 a share, discounted to $19 for environmental liabilities
- Rising corn prices, up 20% year over year, are seen as a tailwind for the crop business
Corteva (CTVA) stock traded near $12.77 to $13.54 this week, up as much as 9% after JPMorgan raised its rating. Analyst Jeffrey Zekauskas moved the stock to Buy from Hold on Tuesday.
His price target also changed, landing at $19. That’s down sharply from the old $83 target, but the number is misleading.
Corteva split into two separate companies on Oct. 1. The new Corteva kept the crop protection business. The seed technology arm, once DuPont’s Pioneer unit, became its own company called Vylor.
Shareholders got one share of Vylor for every Corteva share they held. So on a combined basis, not much actually changed in value.
Vylor opened trading at $68.26 after the split. Corteva stock, by comparison, dropped 84% on Oct. 1 simply because the seed business was no longer part of it.
Trading volume tells its own story here. New Corteva saw 88 million shares change hands on day one, then 79 million, then 183 million by day three.
Vylor’s volume was far lighter, at 15 million, 14 million, and 17 million shares over the same stretch. Investors appear to be sorting out which stock fits their portfolio.
What JPMorgan Sees in Corteva
Zekauskas values the crop chemical business at about 10 times 2027 EBITDA. That works out to roughly $21 a share before factoring in legal risk.
He trims that to $19 to account for potential PFAS and PFOA environmental liabilities. JPMorgan estimates Corteva’s share of those costs at about $1.3 billion, or $2 a share, if total industry liability hits $8 billion.
The new Corteva runs a 38% gross margin and a 16.5% to 17% EBITDA margin. Net debt is close to zero.
JPMorgan pegs the stock’s EV/EBITDA multiple at 5.7 times for 2027. That’s a one-turn discount compared to rival FMC.
Corn Prices and the Bigger Picture
Benchmark corn prices sit near $5 a bushel, up 20% from a year ago. Higher crop prices tend to help input suppliers like Corteva, since farmers have more cash to spend on chemicals.
Zekauskas also pointed to cost-cutting room. He estimates Corteva could trim $200 million a year from its cost structure.
The company plans to license new crop chemical molecules from other industry players. That approach could add growth without heavy research spending.
JPMorgan isn’t alone in liking the stock. The average analyst price target for Corteva sits near $17, according to FactSet, about 35% above recent levels.
Not every firm agrees on numbers, though their outlooks for Corteva’s direction line up. Oppenheimer set its target at $17, down from $95 pre-split, while keeping an Outperform rating.
BMO Capital landed at $15, citing crop protection headwinds alongside the seed separation. Morgan Stanley went higher, at $18, pointing to Corteva’s research pipeline as a growth driver.
Mizuho kept an Outperform rating on Vylor specifically, with a $97 price target. The firm noted Vylor makes up a large chunk of the old company’s EBITDA.
Oppenheimer also reiterated Outperform on Vylor, with a $95 target. For now, the post-split dust is still settling across both stocks.
Stop guessing and start investing with confidence. KnockoutStocks gives you the AI insights, market intelligence, and stock research you need to spot opportunities, cut through the noise, and make smarter investment decisions — all in one powerful platform.
Sign up today and get 50% OFF full access to our premium stock picks.
Simply use coupon code SPECIAL50 at checkout to claim your exclusive discount.







